- Case report
- Open Access
Acute myocardial infarction and coronary vasospasm associated with the ingestion of cayenne pepper pills in a 25-year-old male
© Sogut et al; licensee Springer. 2012
- Received: 5 September 2011
- Accepted: 20 January 2012
- Published: 20 January 2012
Capsaicin, one of the major active components of cayenne pepper pills, is an over-the-counter substance with sympathomimetic activity used commonly by young individuals for weight loss. Here we report the case of a previously healthy young male who developed severe chest pain after using cayenne pepper pills for slimming and sustained an extensive inferior myocardial infarction. Electrocardiography combined with a bedside transthoracic echocardiogram confirmed the diagnosis of acute myocardial infarction. The patient denied using illicit substances, and he had no risk factors for coronary artery disease. His medication history revealed that he had recently started taking cayenne pepper pills for slimming. A subsequent coronary angiogram revealed patent coronary arteries, suggesting that the mechanism was vasospasm. We postulate that the patient developed acute coronary vasospasm and a myocardial infarction in the presence of this known sympathomimetic agent. This case highlights the potential danger of capsaicin, even when used by otherwise healthy individuals.
- Acute Myocardial Infarction
- Normal Coronary Artery
- Chili Pepper
- Coronary Artery Spasm
For slimming, the use of weight loss pills flavored with Mexican pepper seeds is common among females. Originally called "La Jiao Shou Shen," cayenne (chili) pepper pills have been imported to Turkey from the Far East. China and Russia are the only countries in the world where chili pepper pills are sold. Capsules containing 400 and 600 mg of chili pepper are sold for weight loss; patches and gels are used for pain relief and slimming, respectively .
Cayenne pepper pills contain pungent ingredients called capsaicinoids, and one of the active components of cayenne pepper is capsaicin . Capsaicin accelerates energy expenditure and suppresses body fat accumulation by activating the sympathetic nervous system (SNS) in animals and humans [3–6]. However, this substance is associated with cardiotoxicity, including coronary vasospasm, supraventricular tachycardia, and acute atrial fibrillation [1, 7]. Capsaicin also prolongs the cardiac action potential in atrial and ventricular myocytes, an effect that is associated with the inhibition of potassium currents [8, 9]. Coronary vasospasm and acute myocardial infarction (AMI) associated with the use of topical capsaicin patches to relieve back pain have been reported recently . Here, we describe the first reported case of coronary vasospasm and AMI suspected of being caused by the use of cayenne pepper pills for slimming.
Chili peppers are a major source of natural capsaicinoids, including capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homodihydrocapsaicin, and homocapsaicin . Capsaicin is the active component of chili peppers and has multiple pharmacological and physiological effects, including analgesic, anticancer, anti-inflammatory, antioxidant, and anti-obesity effects; moreover, it promotes the rapid elimination of toxins and fats generated in the body [5, 10]. The characteristic effects of capsaicinoids may be of therapeutic value for pain relief, cancer prevention, and weight loss [7, 10]. In addition to these therapeutic effects, capsaicinoids have various side effects on the cardiovascular system [1, 7]. In animal experiments, capsaicinoids accelerated catecholamine secretion by activating the adrenal sympathetic efferent nerve [4, 11]. Capsaicinoids act on the cardiovascular system largely as potential agonists of capsaicin receptor or transient receptor potential vanilloid subfamily member 1 (TRPV1) . Hachiya et al.  reported that capsaicin enhances adrenal medullary adrenaline secretion in humans, which transiently elevates the blood pressure and heart rate. In isolated working rat hearts, Szolcsányi et al.  found that capsaicin elicited concentration-dependent constriction of the coronary arteries and decreased coronary flow by acting on VR1 capsaicin receptors. They suggested that capsaicin-induced coronary artery spasm in the rat heart was mediated by endothelin release from sensory nerve terminals, resulting in deteriorated cardiac function. In our case, we attributed the occurrence of vasospasm and AMI to the use of cayenne pepper pills for weight loss, which might have evoked a coronary artery spasm by eliciting neural endothelin release and catecholamine secretion, indicating marked sympathomimetic activity as a result of its intense stimulatory effect on the SNS.
Myocardial infarction in teenagers and young adults is uncommon, and the underlying mechanism is related mainly to congenital coronary anomalies, coagulopathy, premature atherosclerosis, coronary artery spasm, or drugs . Most commonly used stimulants (e.g., cocaine, cigarettes, marijuana, alcohol, butane, and amphetamines) have been reported to cause AMI secondary to intense coronary vasospasm in youths when used alone or in combination [14, 15]. These substances exaggerate the vasospastic activity of other drugs, enhance endothelial dysfunction, increase platelet aggregation, increase sympathetic activity, and decrease the myocardial oxygen supply . In our case, there was no history of substance abuse. In addition, the patient had no cardiac risk factors, and his chest pain began after using oral capsaicin for slimming for 5 days. The patient sustained an extensive inferior myocardial infarction.
Coronary artery spasm in association with myocardial infarction primarily affects younger individuals with or without underlying atherosclerotic lesions [14, 15]. However, a substantial number of cases have angiographically normal coronary arteries [15–18]. Myocardial infarction with normal coronary arteries is an uncommon phenomenon resulting from numerous conditions, but the clinical presentation is similar to that of myocardial infarction with coronary atherosclerosis. Cigarette smokers and cocaine users are more prone to developing this condition . The possible mechanisms of myocardial infarction in individuals with normal coronary arteries are a hypercoagulable state, coronary embolism, an imbalance between oxygen demand and supply, intense sympathetic stimulation, non-atherosclerotic coronary disease, coronary trauma, coronary vasospasm, coronary thrombosis, and endothelial dysfunction [14, 17]. It has been recommended that once normal coronary arteries are identified on subsequent angiography, calcium channel blockers should be added to the treatment regimen, since coronary vasospasm seems to play a major role in the pathophysiology of this condition .
The majority of cases with clinical and electrocardiographic signs of acute coronary events have been diagnosed based on the patency of coronary vessels seen in an elective coronary angiogram [16–18]. Since the provocation of coronary artery spasm following AMI posses a high risk, we did not perform a provocation test in our case. After coronary angiography showing no occlusive lesions, our patient was treated with the calcium antagonist diltiazem. The observed improvement in his clinical and electrocardiographic findings and the relief of his chest pain after stopping the cayenne pepper pills support the role of capsaicin in the development of coronary vasospasm through increased sympathetic stimulation.
This is the first report linking the use of cayenne pepper pills for slimming to an acute coronary syndrome, and one of the few cases associated with capsaicin. Capsaicin, a sympathomimetic agent, may be implicated in the initiation of coronary vasospasm and acute myocardial infarction in the absence of substance abuse, particularly in previously healthy teenagers and young adults. We suggest that this product, which may increase the risk of life-threatening cardiovascular events, be closely supervised and controlled by relevant institutions worldwide.
The authors obtained permission from the patient to display the images and photographs in scientific journals.
Ozgur Sogut, Halil Kaya, and Mehmet Tahir Gokdemir are at Harran University, School of Medicine, Department of Emergency Medicine, Sanliurfa, Turkey. Yusuf Sezen is at Harran University, School of Medicine, Department of Cardiology, Sanliurfa, Turkey.
- Sogut O, Kaya H, Gokdemir MT, Nimetoglu MS, Solduk L: Cardiotoxicity developed after the use of cayenne pepper pill for slimming: A report of two cases. Turk J Emerg Med 2010,10(3):133–136.Google Scholar
- Szallasi A, Blumberg PM: Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999,51(2):159–212.PubMedGoogle Scholar
- Kawada T, Hagihara K, Iwai K: Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J Nutr 1986,116(7):1272–1278.PubMedGoogle Scholar
- Ohnuki K, Haramizu S, Oki K, Watanabe T, Yazawa S, Fushiki T: Administration of capsiate, a non-pungent capsaicin analog, promotes energy metabolism and suppresses body fat accumulation in mice. Biosci Biotechnol Biochem 2001,65(12):2735–2740. 10.1271/bbb.65.2735PubMedView ArticleGoogle Scholar
- Kawabata F, Inoue N, Yazawa S, Kawada T, Inoue K, Fushiki T: Effects of CH-19 sweet, a non-pungent cultivar of red pepper, in decreasing the body weight and suppressing body fat accumulation by sympathetic nerve activation in humans. Biosci Biotechnol Biochem 2006,70(12):2824–2835. 10.1271/bbb.60206PubMedView ArticleGoogle Scholar
- Reinbach HC, Smeets A, Martinussen T, Møller P, Westerterp-Plantenga MS: Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance. Clin Nutr 2009,28(3):260–265. 10.1016/j.clnu.2009.01.010PubMedView ArticleGoogle Scholar
- Akçay AB, Ozcan T, Seyis S, Acele A: Coronary vasospasm and acute myocardial infarction induced by a topical capsaicin patch. Turk Kardiyol Dern Ars 2009,37(7):497–500.PubMedGoogle Scholar
- Castle NA: Differential inhibition of potassium currents in rat ventricular myocytes by capsaicin. Cardiovasc Res 1992,26(11):1137–1144. 10.1093/cvr/26.11.1137PubMedView ArticleGoogle Scholar
- Kehl SJ: Block by capsaicin of voltage-gated K+ currents in melanotrophs of the rat pituitary. Br J Pharmacol 1994,112(2):616–624.PubMed CentralPubMedView ArticleGoogle Scholar
- Luo XJ, Peng J, Li YJ: Recent advances in the study on capsaicinoids and capsinoids. Eur J Pharmacol 2011,650(1):1–7. 10.1016/j.ejphar.2010.09.074PubMedView ArticleGoogle Scholar
- Watanabe T, Kawada T, Kurosawa M, Sato A, Iwai K: Adrenal sympathetic efferent nerve and catecholamine secretion excitation caused by capsaicin in rats. Am J Physiol 1988,255(1Pt1):E23-E27.PubMedGoogle Scholar
- Hachiya S, Kawabata F, Ohnuki K, Inoue N, Yoneda H, Yazawa S, Fushiki T: Effects of CH-19 Sweet, a non-pungent cultivar of red pepper, on sympathetic nervous activity, body temperature, heart rate, and blood pressure in humans. Biosci Biotechnol Biochem 2007,71(3):671–676. 10.1271/bbb.60359PubMedView ArticleGoogle Scholar
- Szolcsanyi J, Oroszi G, Nemeth J, Szilvassy Z, Blasig IE, Tosaki A: Functional and biochemical evidence for capsaicin-induced neural endothelin release in isolated working rat heart. Eur J Pharmacol 2001,419(2–3):215–221. 10.1016/S0014-2999(01)00973-6PubMedView ArticleGoogle Scholar
- El Menyar AA: Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. J Postgrad Med 2006,52(1):51–56.PubMedGoogle Scholar
- Williams MJ, Restieaux NJ, Low CJ: Myocardial infarction in young people with normal coronary arteries. Heart 1998,79(2):191–194.PubMed CentralPubMedView ArticleGoogle Scholar
- Pederson KJ, Kuntz DH, Garbe GJ: Acute myocardial ischemia associated with ingestion of bupropion and pseudoephedrine in a 21-year-old man. Can J Cardiol 2001,17(5):599–601.PubMedGoogle Scholar
- Ton A, Khan IA: Myocardial infarction with normal coronary arteries: the pathologic and clinical perspectives. Angiology 2001,52(5):299–304. 10.1177/000331970105200501View ArticleGoogle Scholar
- Manini AF, Kabrhel C, Thomsen TW: Acute myocardial infarction after over-the-counter use of pseudoephedrine. Ann Emerg Med 2005,45(2):213–216. 10.1016/j.annemergmed.2004.07.003PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.